Erratum: Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy (JAMA Otolaryngology-Head & Neck Surgery (2015) doi:10.1001/jamaoto.2015.136);Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy

JAMA Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 5, 2015, Pages 457-462

  Trosman, Samuel J ^a   Koyfman, Shlomo A ^b   Ward, Matthew C ^b   Al Khudari, Samer ^c   Nwizu, Tobenna ^b   Greskovich, John F ^b   Lamarre, Eric D ^a   Scharpf, Joseph ^a   Khan, Mumtaz J ^a   Lorenz, Robert R ^a   Adelstein, David J ^b   Burkey, Brian B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE; BRAIN; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; KIDNEY; LUNG; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; RETROSPECTIVE STUDY; SKELETAL MUSCLE; SKIN; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; WART VIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; MIDDLE AGED; NEOPLASM METASTASIS; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; REGISTER; SURVIVAL RATE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE;

EID: 84929643329     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2015.136     Document Type: Erratum

References (23)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
2. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720.
3. O'Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013;31(5):543-550.
4. Posner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22(5):1071-1077.
5. Huang SH, Perez-Ordonez B, Liu F-F, et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(1):276-283.
6. Mehra R, Egloff AM, Li S, et al Eastern Cooperative Oncology Group. Analysis of HPV and ERCC1 in recurrent or metastatic squamous cell carcinoma of the head and neck [abstract 6006]. J Clin Oncol. 2013;31(15)(suppl):15S.
7. Sinha P, Thorstad WT, Nussenbaum B, et al. Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. Oral Oncol. 2014;50(1):45-51.
8. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-269.
9. Argiris A, Li S, Ghebremichael M, et al. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials. Ann Oncol. 2014;25(7):1410-1416.
10. Fakhry C, Zhang Q, Nguyen-Tan PF, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014;32(30):3365-3373.
11. O'Sullivan B, Huang SH, Perez-Ordonez B, et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol. 2012;103(1):49-56.
12. Spector ME, Gallagher KK, Light E, et al University of Michigan Head Neck Specialized Program of Research Excellence (SPORE) Program. Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck. 2012;34(12):1727-1733.
13. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol.2012;36(7):945-954.
14. Grønhøj Larsen C, Gyldenløve M, Jensen DH, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110(6):1587-1594.
15. Rodriguez CP, Adelstein DJ, Rybicki LA, et al. A randomized phase III study of 2 cisplatin based chemoradiation (CCRT) regimens in locally advanced head and neck squamous cell carcinoma (LAHNSCC): the impact of changing disease epidemiology on contemporary trial design [published online June 7, 2014]. Head Neck. doi:10.1002/hed.23794.
16. Huang SH, Perez-Ordonez B, Weinreb I, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 2013;49(1):79-85.
17. Ruzevick J, Olivi A, Westra WH. Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol. 2013;112(3):449-454.
18. Al-Khudari S, Guo S, Chen Y, et al. Solitary dural metastasis at presentation in a patient with untreated human papillomavirus-associated squamous cell carcinoma of the oropharynx. Head Neck. 2014;36(10):103-105.
19. Müller S, Khuri FR, Kono SA, Beitler JJ, Shin DM, Saba NF. HPV positive squamous cell carcinoma of the oropharynx: are we observing an unusual pattern of metastases? Head Neck Pathol. 2012;6(3):336-344.
20. El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34(4):459-461.
21. Bussu F, Sali M, Gallus R, et al. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region: is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer. 2013;108(5):1157-1162.
22. Bussu F, Sali M, Gallus R, et al. Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators-a pilot study. Int J Radiat Oncol Biol Phys. 2014;89(5):1115-1120.
23. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121(11):2465-2472.